Baseline characteristics of 98 patients indicated for benzbromarone
| Patient characteristics | N (%) |
|---|---|
| Sex | |
| -Male | 8 (90%) |
| -Female | 10 (10%) |
| Duration of symptoms prior to inclusion | |
| -Years (SD) | 8.2 (6.5) |
| Age | |
| -Mean (SD) | 70 (12) |
| Initial dose of benzbromarone | |
| -50 mg QD | 15 (15%) |
| -100 mg QD | 81 (83%) |
| -200 mg QD | 2 (2%) |
| Initial combination therapy | |
| -With allopurinol | 67 (68%) |
| -With febuxostat | 3 (3%) |
| Initial sUA | |
| -Mean (SD), mmol/L | 0.45 (0.12) |
| Initial eGFR | |
| -Mean (SD), mL/min | 54 (18) |
SD: standard deviation